Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Insights into melanoma: targeting the mTOR pathway for therapeutics
Helena Pópulo, Paula Soares, José Manuel Lopes
Expert Opinion on Therapeutic Targets (2012) Vol. 16, Iss. 7, pp. 689-705
Closed Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Melanoma treatment in review
Beatriz Domingues, José Manuel Lopes, Paula Soares, et al.
ImmunoTargets and Therapy (2018) Vol. Volume 7, pp. 35-49
Open Access | Times Cited: 601
Skin cancer biology and barriers to treatment: Recent applications of polymeric micro/nanostructures
Nazeer Hussain Khan, Maria Mir, Lei Qian, et al.
Journal of Advanced Research (2021) Vol. 36, pp. 223-247
Open Access | Times Cited: 143
TERT Promoter Mutations in Skin Cancer: The Effects of Sun Exposure and X-Irradiation
Helena Pópulo, Paula Boaventura, João Vinagre, et al.
Journal of Investigative Dermatology (2014) Vol. 134, Iss. 8, pp. 2251-2257
Open Access | Times Cited: 125
Melanoma therapeutics: a literature review
Pavan Kumar Dhanyamraju, Trupti Patel
Journal of Biomedical Research (2022) Vol. 36, Iss. 2, pp. 77-77
Open Access | Times Cited: 40
Itraconazole exerts its anti-melanoma effect by suppressing Hedgehog, Wnt, and PI3K/mTOR signaling pathways
Guanzhao Liang, Musang Liu, Qiong Wang, et al.
Oncotarget (2017) Vol. 8, Iss. 17, pp. 28510-28525
Open Access | Times Cited: 68
Anti-Tumor Effect of Adipose Tissue Derived-Mesenchymal Stem Cells Expressing Interferon-β and Treatment with Cisplatin in a Xenograft Mouse Model for Canine Melanoma
Jin Ok Ahn, Hee Woo Lee, Kyoung‐Won Seo, et al.
PLoS ONE (2013) Vol. 8, Iss. 9, pp. e74897-e74897
Open Access | Times Cited: 59
Signal Transduction in Human Cutaneous Melanoma and Target Drugs
Anatoly B. Uzdensky, Svetlana Demyanenko, Mikhail Bibov
Current Cancer Drug Targets (2013) Vol. 13, Iss. 8, pp. 843-866
Closed Access | Times Cited: 56
Estrogen promotes fat mass and obesity-associated protein nuclear localization and enhances endometrial cancer cell proliferation via the mTOR signaling pathway
Yaping Zhu, Jiaqi Shen, LIYAN GAO, et al.
Oncology Reports (2016) Vol. 35, Iss. 4, pp. 2391-2397
Open Access | Times Cited: 56
Potential therapeutic effects of the MTOR inhibitors for preventing ageing and progeria‐related disorders
Camilla Evangelisti, Vittoria Cenni, Giovanna Lattanzi
British Journal of Clinical Pharmacology (2016) Vol. 82, Iss. 5, pp. 1229-1244
Open Access | Times Cited: 51
Metal–organic framework microneedles for precision transdermal drug delivery: design strategy and therapeutic potential
Yutong Jing, Xueting Liu, Yajing Zhu, et al.
Nanoscale (2025)
Closed Access
Papillary Thyroid Microcarcinoma
Paula Soares, Ricardo Celestino, Adriana Gaspar da Rocha, et al.
International Journal of Surgical Pathology (2014) Vol. 22, Iss. 2, pp. 113-119
Closed Access | Times Cited: 44
The outstanding role of miR-132-3p in carcinogenesis of solid tumors
Milad Rafat, Mahta Moraghebi, Masoomeh Afsa, et al.
Human Cell (2021) Vol. 34, Iss. 4, pp. 1051-1065
Closed Access | Times Cited: 29
Metastatic melanoma – a review of current and future drugs
Tiago R. Velho
Drugs in Context (2012), pp. 1-17
Open Access | Times Cited: 43
High frequency of PTEN mutations in nevi and melanomas from xeroderma pigmentosum patients
Taro Masaki, Yun Wang, John J. DiGiovanna, et al.
Pigment Cell & Melanoma Research (2014) Vol. 27, Iss. 3, pp. 454-464
Open Access | Times Cited: 39
Exploring major signaling cascades in melanomagenesis: a rationale route for targetted skin cancer therapy
Paola M. Dantonio, Marianne Klein, Maria Renata Valente Brandão Freire, et al.
Bioscience Reports (2018) Vol. 38, Iss. 5
Open Access | Times Cited: 34
Furthering the design and the discovery of small molecule ATP-competitive mTOR inhibitors as an effective cancer treatment
Xiaoqing Lv, Xiaodong Ma, Yongzhou Hu
Expert Opinion on Drug Discovery (2013) Vol. 8, Iss. 8, pp. 991-1012
Closed Access | Times Cited: 31
Overexpression of pyruvate dehydrogenase kinase supports dichloroacetate as a candidate for cutaneous melanoma therapy
Helena Pópulo, Regina Caldas, José Manuel Lopes, et al.
Expert Opinion on Therapeutic Targets (2015) Vol. 19, Iss. 6, pp. 733-745
Closed Access | Times Cited: 25
Design and synthesis of Ag NPs/chitosan-starch nano-biocomposite as a modern anti-human malignant melanoma drug
Zunjiang Zhao, Linsen Fang, Dalun Lv, et al.
International Journal of Biological Macromolecules (2023) Vol. 236, pp. 123823-123823
Closed Access | Times Cited: 7
Poly(N-vinylcaprolactam)–Gold Nanorods–5 Fluorouracil Hydrogels: In the Quest of a Material for Topical Therapies against Melanoma Skin Cancer
Mirian A. González‐Ayón, Alondra Rochin-Galaviz, Arturo Zizumbo‐López, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1097-1097
Open Access | Times Cited: 7
MicroRNA-9 suppresses the growth, migration, and invasion of malignant melanoma cells via targeting NRP1
Dan Xu, Xiaofeng Chen, Quanyong He, et al.
OncoTargets and Therapy (2016) Vol. Volume 9, pp. 7047-7057
Open Access | Times Cited: 21
Knockdown of long non-coding RNA MIR155HG suppresses melanoma cell proliferation, and deregulated MIR155HG in melanoma is associated with M1/M2 balance and macrophage infiltration
Rui Liu, Xian Sun, Zhen Hu, et al.
Cells and Development (2022) Vol. 170, pp. 203768-203768
Open Access | Times Cited: 12
MicroRNA-9 inhibits the proliferation and migration of malignant melanoma cells via targeting sirituin 1
Pingyuan Bu, Chengqun Luo, Quanyong He, et al.
Experimental and Therapeutic Medicine (2017) Vol. 14, Iss. 2, pp. 931-938
Open Access | Times Cited: 21
Obesity and melanoma: Exploring molecular links
Jiezhong Chen, Mengna Chi, Chen Chen, et al.
Journal of Cellular Biochemistry (2013) Vol. 114, Iss. 9, pp. 1955-1961
Closed Access | Times Cited: 20
VS-5584, a Novel PI3K-mTOR Dual Inhibitor, Inhibits Melanoma Cell Growth In Vitro and In Vivo
Zheren Shao, Qi Bao, Fangzhen Jiang, et al.
PLoS ONE (2015) Vol. 10, Iss. 7, pp. e0132655-e0132655
Open Access | Times Cited: 20
Liposomal C6 Ceramide Activates Protein Phosphatase 1 to Inhibit Melanoma Cells
Fangzhen Jiang, Kai Jin, Shenyu Huang, et al.
PLoS ONE (2016) Vol. 11, Iss. 9, pp. e0159849-e0159849
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top